×
Back to Agenda
Session 4: AI, Digitalisation and Innovation in Pharmacovigilance
Session Chair(s)
Maarten Lagendijk, MSc
Deputy EU QPPV, MSD, Netherlands
Sina Schader, DrMed
Head of QPPV Office and EU QPPV, AbbVie, Germany
QPPV Oversight and Training on AI
Speaker(s)
Speaker Invited
, Switzerland
Health Authority Expectations on AI
Speaker Invited
, United Kingdom
AI Best Practices: Big Pharma Examples
Fabian Heisig
Head Global Drug Safety & QPPV, Chief Medical Officer, Grünenthal GmbH, Germany
QPPV Oversight and Training on AI
Have an account?